Trial
NCT04468360
Pharmacokinetic Study for IV Allopregnanolone
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boston University
Collaborators
National Institute of Mental Health (NIMH)
Condition
Pharmacokinetic Study
Intervention
PK-1 Good Manufacturing Practices (GMP) allopregnanolone (Allo) with Dexolve in 0.9% saline for infusion manufactured by the University of California, Davis
Why stopped
The investigator moved to another institution; only preliminary data from pharmacokinetic studies were collected at Boston University School of Medicine/Boston Medical Center.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-02